PMID- 18441471
OWN - NLM
STAT- MEDLINE
DCOM- 20080911
LR  - 20190819
IS  - 1346-9843 (Print)
IS  - 1346-9843 (Linking)
VI  - 72
IP  - 5
DP  - 2008 May
TI  - Infliximab treatment for refractory Kawasaki disease with coronary artery 
      aneurysm.
PG  - 850-2
AB  - Tumor necrosis factor-alpha (TNF-alpha) is considered to be 1 of the factors that 
      induce vasculitis, including coronary artery aneurysm (CA), in Kawasaki disease 
      (KD), because the blood concentration of TNF-alpha is higher in patients with CA 
      compared with those without. Therefore, an anti-TNF-alphaagent (infliximab) was 
      administered to a 1-month-old girl with refractory KD complicated by CA and 
      subsequently, the CA improved and KD was controlled without complications 20 
      months after the onset.
FAU - Oishi, Taku
AU  - Oishi T
AD  - Department of Pediatrics, Kochi National Hospital, Kochi, Japan.
FAU - Fujieda, Mikiya
AU  - Fujieda M
FAU - Shiraishi, Taisuke
AU  - Shiraishi T
FAU - Ono, Miki
AU  - Ono M
FAU - Inoue, Kazuo
AU  - Inoue K
FAU - Takahashi, Akiyoshi
AU  - Takahashi A
FAU - Ogura, Hideo
AU  - Ogura H
FAU - Wakiguchi, Hiroshi
AU  - Wakiguchi H
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Japan
TA  - Circ J
JT  - Circulation journal : official journal of the Japanese Circulation Society
JID - 101137683
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (Antibodies, Monoclonal)
RN  - B72HH48FLU (Infliximab)
SB  - IM
EIN - Circ J. 2008 Jul;72(7):1212
MH  - Anti-Inflammatory Agents/*administration & dosage
MH  - Antibodies, Monoclonal/*administration & dosage
MH  - Coronary Aneurysm/complications/diagnostic imaging/*drug therapy
MH  - Drug Resistance
MH  - Echocardiography
MH  - Female
MH  - Humans
MH  - Infant, Newborn
MH  - Infliximab
MH  - Mucocutaneous Lymph Node Syndrome/complications/diagnostic imaging/*drug therapy
EDAT- 2008/04/29 09:00
MHDA- 2008/09/13 09:00
CRDT- 2008/04/29 09:00
PHST- 2008/04/29 09:00 [pubmed]
PHST- 2008/09/13 09:00 [medline]
PHST- 2008/04/29 09:00 [entrez]
AID - JST.JSTAGE/circj/72.850 [pii]
AID - 10.1253/circj.72.850 [doi]
PST - ppublish
SO  - Circ J. 2008 May;72(5):850-2. doi: 10.1253/circj.72.850.